Bharat Parenterals Ltd approved the allotment of 367,516 equity shares at ₹1,479.90 each, totaling ₹54.39 crores, to facilitate the acquisition of subsidiaries, and reappointed Mr. Bharatkumar R. Desai as Managing Director for five years starting October 1, 2024.